Modulation of oxidative stress and mitochondrial function by the ketogenic diet

Epilepsy Research

Volumn 100, Issue 3, 2012, Pages 295-303

  Milder, Julie ^a   Patel, Manisha ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Epilepsy; Glutathione; Hyperexcitability; Mitochondria; Reactive oxygen species; Redox; Seizure

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; ELECTROPHILE; GLUTATHIONE; HYDROGEN PEROXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; BIOENERGY; CELL LEVEL; CLINICAL EFFECTIVENESS; DETOXIFICATION; DISEASE ASSOCIATION; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME SYNTHESIS; EPILEPSY; HUMAN; INTRACELLULAR SIGNALING; KETOGENIC DIET; METABOLISM; MITOCHONDRIAL FUNCTION; MITOCHONDRION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; SEIZURE;

ANIMALS; GLUTATHIONE; HUMANS; KETOGENIC DIET; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84864084943     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.09.021     Document Type: Article

References (81)

1. Abe K., Nakanishi K., Saito H. The anticonvulsive effect of glutathione in mice. Biol. Pharm. Bull. 1999, 22:1177-1179.
2. Abe K., Nakanishi K., Saito H. The possible role of endogenous glutathione as an anticonvulsant in mice. Brain Res. 2000, 854:235-238.
3. Alam J., Stewart D., Touchard C., Boinapally S., Choi A.M., Cook J.L. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 1999, 274:26071-26078.
4. Ando Y., Brannstrom T., Uchida K., Nyhlin N., Nasman B., Suhr O., Yamashita T., Olsson T., El Salhy M., Uchino M., Ando M. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J. Neurol. Sci. 1998, 156:172-176.
5. Arancio O., Kiebler M., Lee C.J., Lev-Ram V., Tsien R.Y., Kandel E.R., Hawkins R.D. Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons. Cell 1996, 87:1025-1035.
6. Bough K.J., Wetherington J., Hassel B., Pare J.F., Gawryluk J.W., Greene J.G., Shaw R., Smith Y., Geiger J.D., Dingledine R.J. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 2006, 60:223-235.
7. Cai J., Jones D.P. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J. Biol. Chem. 1998, 273:11401-11404.
8. Chen Z.H., Saito Y., Yoshida Y., Sekine A., Noguchi N., Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J. Biol. Chem. 2005, 280:41921-41927.
9. Dash P.K., Zhao J., Orsi S.A., Zhang M., Moore A.N. Sulforaphane improves cognitive function administered following traumatic brain injury. Neurosci. Lett. 2009, 460:103-107.
10. Day A.M., Veal E.A. Hydrogen peroxide-sensitive cysteines in the Sty1 MAPK regulate the transcriptional response to oxidative stress. J. Biol. Chem. 2010, 285:7505-7516.
11. Dickinson D.A., Iles K.E., Watanabe N., Iwamoto T., Zhang H., Krzywanski D.M., Forman H.J. 4-Hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells. Free Radic. Biol. Med. 2002, 33:974.
12. Dinkova-Kostova A.T., Massiah M.A., Bozak R.E., Hicks R.J., Talalay P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3404-3409.
13. Erickson A.M., Nevarea Z., Gipp J.J., Mulcahy R.T. Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. Revision of the ARE consensus sequence. J. Biol. Chem. 2002, 277:30730-30737.
14. Esterbauer H., Jurgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 1987, 28:495-509.
15. Gardner P.R., Fridovich I. Inactivation-reactivation of aconitase in Escherichia coli. A sensitive measure of superoxide radical. J. Biol. Chem. 1992, 267:8757-8763.
16. Gil L., Siems W., Mazurek B., Gross J., Schroeder P., Voss P., Grune T. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic. Res. 2006, 40:495-505.
17. Hensley K., Maidt M.L., Yu Z., Sang H., Markesbery W.R., Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 1998, 18:8126-8132.
18. Huang C.S., Chang L.S., Anderson M.E., Meister A. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J. Biol. Chem. 1993, 268:19675-19680.
19. Huang H.C., Nguyen T., Pickett C.B. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12475-12480.
20. Huang H.C., Nguyen T., Pickett C.B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 2002, 277:42769-42774.
21. Huang R.Q., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J. Pharmacol. Exp. Ther. 2001, 298:986-995.
22. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:9265-9269.
23. Ishii T., Itoh K., Ruiz E., Leake D.S., Unoki H., Yamamoto M., Mann G.E. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 2004, 94:609-616.
24. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13:76-86.
25. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
26. Jacobsson S.O., Cassel G.E., Persson S.A. Increased levels of nitrogen oxides and lipid peroxidation in the rat brain after soman-induced seizures. Arch. Toxicol. 1999, 73:269-273.
27. Jarrett S.G., Milder J.B., Liang L.P., Patel M. The ketogenic diet increases mitochondrial glutathione levels. J. Neurochem. 2008, 106:1044-1051.
28. Jonas C.R., Estivariz C.F., Jones D.P., Gu L.H., Wallace T.M., Diaz E.E., Pascal R.R., Cotsonis G.A., Ziegler T.R. Keratinocyte growth factor enhances glutathione redox state in rat intestinal mucosa during nutritional repletion. J. Nutr. 1999, 129:1278-1284.
29. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 1994, 350:9-12.
30. Kim do Y., Davis L.M., Sullivan P.G., Maalouf M., Simeone T.A., van Brederode J., Rho J.M. Ketone bodies are protective against oxidative stress in neocortical neurons. J. Neurochem. 2007, 101:1316-1326.
31. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24:7130-7139.
32. Kraft A.D., Lee J.M., Johnson D.A., Kan Y.W., Johnson J.A. Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J. Neurochem. 2006, 98:1852-1865.
33. Kunz W.S., Kudin A.P., Vielhaber S., Blumcke I., Zuschratter W., Schramm J., Beck H., Elger C.E. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann. Neurol. 2000, 48:766-773.
34. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., Darley-Usmar V.M. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 2004, 378:373-382.
35. Li W., Yu S., Liu T., Kim J.H., Blank V., Li H., Kong A.N. Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif. Biochim. Biophys. Acta 2008, 1783:1847-1856.
36. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olsen J.L., Nobel L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.H. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 1995, 11:376-381.
37. Liang L.P., Patel M. Mitochondrial oxidative stress and increased seizure susceptibility in Sod2(-/+) mice. Free Radic. Biol. Med. 2004, 36:542-554.
38. Liang L.P., Patel M. Seizure-induced changes in mitochondrial redox status. Free Radic. Biol. Med. 2006, 40:316-322.
39. Liang L.P., Ho Y.S., Patel M. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 2000, 101:563-570.
40. Liu R.M., Gao L., Choi J., Forman H.J. Gamma-glutamylcysteine synthetase: mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal. Am. J. Physiol. 1998, 275:L861-L869.
41. Maalouf M., Sullivan P.G., Davis L., Kim D.Y., Rho J.M. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 2007, 145:256-264.
42. Marini M.G., Chan K., Casula L., Kan Y.W., Cao A., Moi P. hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2. J. Biol. Chem. 1997, 272:16490-16497.
43. Matalon R., Stumpf D.A., Michals K., Hart R.D., Parks J.K., Goodman S.I. Lipoamide dehydrogenase deficiency with primary lactic acidosis: favorable response to treatment with oral lipoic acid. J. Pediatr. 1984, 104:65-69.
44. Michel P., Eggert W., Albrecht-Nebe H., Grune T. Increased lipid peroxidation in children with autoimmune diseases. Acta Paediatr. 1997, 86:609-612.
45. Milder J.B., Liang L.P., Patel M. Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet. Neurobiol. Dis. 2010, 40:238-244.
46. Moinova H.R., Mulcahy R.T. An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. J. Biol. Chem. 1998, 273:14683-14689.
47. Mueller S.G., Trabesinger A.H., Boesiger P., Wieser H.G. Brain glutathione levels in patients with epilepsy measured by in vivo (1)H-MRS. Neurology 2001, 57:1422-1427.
48. Mulcahy R.T., Wartman M.A., Bailey H.H., Gipp J.J. Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J. Biol. Chem. 1997, 272:7445-7454.
49. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., Whitney A., Cross J.H. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008, 7:500-506.
50. Nguyen T., Huang H.C., Pickett C.B. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 2000, 275:15466-15473.
51. Niture S.K., Jain A.K., Jaiswal A.K. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J. Cell Sci. 2009, 122:4452-4464.
52. Patel M., Liang L.P., Hou H., Williams B.B., Kmiec M., Swartz H.M., Fessel J.P., Roberts L.J. Seizure-induced formation of isofurans: novel products of lipid peroxidation whose formation is positively modulated by oxygen tension. J. Neurochem. 2008, 104:264-270.
53. Pavlakis S.G., Phillips P.C., DiMauro S., De Vivo D.C., Rowland L.P. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 1984, 16:481-488.
54. Raines K.W., Bonini M.G., Campbell S.L. Nitric oxide cell signaling: S-nitrosation of Ras superfamily GTPases. Cardiovasc. Res. 2007, 75:229-239.
55. Rebrin I., Sohal R.S. Comparison of thiol redox state of mitochondria and homogenates of various tissues between two strains of mice with different longevities. Exp. Gerontol. 2004, 39:1513-1519.
56. Richman P.G., Meister A. Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J. Biol. Chem. 1975, 250:1422-1426.
57. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 1991, 266:11632-11639.
58. Samiec P.S., Drews-Botsch C., Flagg E.W., Kurtz J.C., Sternberg P., Reed R.L., Jones D.P. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic. Biol. Med. 1998, 24:699-704.
59. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., Smith M.A. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 1997, 68:2092-2097.
60. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991, 10:2247-2258.
61. Selley M.L., Bartlett M.R., McGuiness J.A., Hapel A.J., Ardlie N.G. Determination of the lipid peroxidation product trans-4-hydroxy-2-nonenal in biological samples by high-performance liquid chromatography and combined capillary column gas chromatography-negative-ion chemical ionisation mass spectrometry. J. Chromatogr. 1989, 488:329-340.
62. Shibata N., Nagai R., Uchida K., Horiuchi S., Yamada S., Hirano A., Kawaguchi M., Yamamoto T., Sasaki S., Kobayashi M. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res. 2001, 917:97-104.
63. Shih A.Y., Li P., Murphy T.H. A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J. Neurosci. 2005, 25:10321-10335.
64. Shih A.Y., Imbeault S., Barakauskas V., Erb H., Jiang L., Li P., Murphy T.H. Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 2005, 280:22925-22936.
65. Shoffner J.M., Lott M.T., Lezza A.M., Seibel P., Ballinger S.W., Wallace D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990, 61:931-937.
66. Sleven H., Gibbs J.E., Heales S., Thom M., Cock H.R. Depletion of reduced glutathione precedes inactivation of mitochondrial enzymes following limbic status epilepticus in the rat hippocampus. Neurochem. Int. 2006, 48:75-82.
67. Stamler J.S., Lamas S., Fang F.C. Nitrosylation: the prototypic redox-based signaling mechanism. Cell 2001, 106:675-683.
68. Sullivan P.G., Rippy N.A., Dorenbos K., Concepcion R.C., Agarwal A.K., Rho J.M. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 2004, 55:576-580.
69. Thiele E.A. Assessing the efficacy of antiepileptic treatments: the ketogenic diet. Epilepsia 2003, 44(Suppl. 7):26-29.
70. Tian J., Washizawa N., Gu L.H., Levin M.S., Wang L., Rubin D.C., Mwangi S., Srinivasan S., Gao Y., Jones D.P., Ziegler T.R. Stimulation of colonic mucosal growth associated with oxidized redox status in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R1081-R1090.
71. Toki T., Itoh J., Kitazawa J., Arai K., Hatakeyama K., Akasaka J., Igarashi K., Nomura N., Yokoyama M., Yamamoto M., Ito E. Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif. Oncogene 1997, 14:1901-1910.
72. Tor-Agbidye J., Palmer V.S., Sabri M.I., Craig A.M., Blythe L.L., Spencer P.S. Dietary deficiency of cystine and methionine in rats alters thiol homeostasis required for cyanide detoxification. J. Toxicol. Environ. Health A 1998, 55:583-595.
73. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 1999, 274:2234-2242.
74. Wakabayashi N., Dinkova-Kostova A.T., Holtzclaw W.D., Kang M.I., Kobayashi A., Yamamoto M., Kensler T.W., Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2040-2045.
75. Wilson L.A., Gemin A., Espiritu R., Singh G. ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB J. 2005, 19:2085-2087.
76. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:2696-2701.
77. Yoshino K., Sano M., Fujita M., Tomita I. Formation of aliphatic aldehydes in rat plasma and liver due to vitamin E deficiency. Chem. Pharm. Bull. (Tokyo) 1986, 34:5184-5187.
78. Zhang D.D., Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventives agents and oxidative stress. Mol. Cell. Biol. 2003, 23:8137-8151.
79. Zhao J., Kobori N., Aronowski J., Dash P.K. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci. Lett. 2006, 393:108-112.
80. Zhao J., Moore A.N., Redell J.B., Dash P.K. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J. Neurosci. 2007, 27:10240-10248.
81. Zhao X., Sun G., Zhang J., Strong R., Dash P.K., Kan Y.W., Grotta J.C., Aronowski J. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke 2007, 38:3280-3286.